Rifaximin reduces rehospitalization risk in patients with cirrhosis and overt hepatic encephalopathy

Timely treatment with rifaximin in adherence with clinical practice guidelines following an initial OHE hospitalization was associated with improved short-term and longer-term rehospitalization outcomes, regardless of insurance type.